Blood and Bone Marrow Disorders journal aims to be a premier platform for the publication of high-quality research, clinical studies, and reviews focused on hematologic and bone marrow disorders. The journal's primary objective is to advance the understanding, diagnosis, treatment, and management of blood and bone marrow diseases, contributing to improved patient outcomes and advancing the field of hematology. By providing a comprehensive forum for the dissemination of new findings and insights, the journal seeks to foster collaboration among researchers, clinicians, and healthcare professionals worldwide.

All the manuscripts published by ‘Blood and Bone Marrow Disorders’ undergo rapid, quality and quick review processing by eminent editorial and review team maintaining high standards and ethics of publishing.

The scholarly content published online will be freely available to every reader anywhere in the world to read, download, copy, reuse and distribute, provided the original work is properly cited.

Authors may submit their valuable work via the online submission form or email to the editor’s office at submissions@asterpublications.com

Scope

The scope of Blood and Bone Marrow Disorders includes, but is not limited to:

Hematologic Malignancies: Research on the diagnosis, treatment, and management of blood cancers, including leukemia, lymphoma, myeloma, and related disorders.

Bone Marrow Disorders: Studies focused on disorders affecting the bone marrow, such as myelodysplastic syndromes (MDS), aplastic anemia, and bone marrow failure syndromes.

Anemias: Research addressing the causes, diagnosis, and treatment of various forms of anemia, including iron-deficiency anemia, sickle cell disease, and thalassemias.

Coagulation and Hemostasis: Articles exploring disorders of blood clotting, including hemophilia, thrombophilia, and other coagulopathies, as well as advancements in anticoagulant therapy.

Stem Cell Transplantation: Studies on hematopoietic stem cell transplantation, including autologous and allogeneic transplants, donor selection, conditioning regimens, and post-transplant complications.

Immunohematology: Research on immune-mediated blood disorders, such as autoimmune hemolytic anemia, immune thrombocytopenia (ITP), and transfusion-related complications.

Genetic and Congenital Blood Disorders: Articles on inherited blood disorders, including genetic mutations, molecular diagnostics, and gene therapy approaches.

Pediatric Hematology: Studies focused on blood and bone marrow disorders in children, including congenital conditions, pediatric leukemias, and supportive care strategies.

Translational Research: Research that bridges basic science and clinical practice, including studies on novel therapeutic targets, biomarkers, and personalized medicine approaches in hematology.

Clinical Trials and Emerging Therapies: Reports on clinical trials, new drugs, and emerging therapies for blood and bone marrow disorders, including targeted therapies, immunotherapies, and cellular therapies.

Supportive Care in Hematology: Articles addressing the management of side effects and complications associated with hematologic diseases and their treatments, including infection prevention, transfusion support, and palliative care.

Ethics and Patient Advocacy: Discussions on ethical issues in the treatment of blood and bone marrow disorders, including patient consent, access to care, and the role of patient advocacy groups.

Global Health in Hematology: Research that examines blood and bone marrow disorders in different regions and populations, including challenges in diagnosis and treatment in low-resource settings.

Case Reports and Series: Detailed case reports and case series that provide insights into rare or complex hematologic conditions, offering valuable lessons for clinical practice.

Technological Innovations: Articles exploring advancements in diagnostic and therapeutic technologies, such as next-generation sequencing, flow cytometry, and novel drug delivery systems.

Patient Quality of Life: Research on the impact of blood and bone marrow disorders on patient quality of life, including psychological, social, and economic aspects.

Letters to the Editor and Commentary: Opinion pieces, expert commentaries, and discussions on recent publications, emerging trends, and current issues in the field of hematology.

Blood and Bone Marrow Disorders encourages submissions from researchers, clinicians, and healthcare professionals worldwide, promoting a diverse and inclusive exchange of knowledge that advances the field of blood and bone marrow disorders.

Key Topics

• Hematologic Malignancies
• Bone Marrow Failure Syndromes
• Coagulation Disorders
• Thrombotic Disorders
• Hematologic Manifestations of Systemic Diseases
• Inherited Blood Disorders
• Transfusion Medicine
• Stem Cell Transplantation

Blood and Bone Marrow Disorders follows the Committee on Publication Ethics (COPE) Guidelines for issues of fraud, image manipulation, and duplicate publication.